Why this newly public biotech could become a force in obesity treatments
Metsera Inc. (MTSR), a New York-based biotech that went public on Jan. 31 with some fanfare, has a full portfolio of weight-loss drugs in development, using both the hormones already used in existing ...
Which diabetes drugs are linked to the lowest depression risk?
Compared to other diabetes medications, GLP-1 drugs like Ozempic were associated with a lower risk for depression in a recent ...
Health.com8h
Thyroid Cancer Is Overdiagnosed in the U.S.—Could Ozempic Be Making the Problem Worse?
Recent research found that weight loss drugs like Ozempic may be contributing to a national trend of thyroid cancer ...
Depression risk lower with GLP-1 receptor agonists versus DPP-4 inhibitors in seniors, study reveals
For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with ...
News Medical8h
Why GLP-1 Manufacturing Needs a New Biopharma Approach
GLP-1 receptor agonists are transforming obesity treatment, but manufacturing challenges must be addressed to meet rising ...
Too Old to Operate15h
Depression Risk Lower With GLP-1 Receptor Agonists Versus DPP-4 Inhibitors in Seniors
For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with ...
News Medical16h
Genetic study demonstrates fat-selective weight loss with GLP-1 agonist use
Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have ...
Endocrinology Advisor19h
GLP-1RA Discontinuation More Common in Obesity Without T2D
GLP-1RA discontinuation and lack of reinitiation was more common among patients with obesity and without type 2 diabetes than with type 2 diabetes.
Modern Healthcare23h
Hims & Hers pivots as semaglutide shortage ends
Hims & Hers co-founder and CEO Andrew Dudum said the company will pivot and focus on different offerings such as its ...
2minutemedicine.com1d
Glucagon-like peptide-1 receptor agonists associated with lower depression risk in older adults with diabetes
In this target trial emulation, glucagon-like peptide-1 receptor agonists (GLP-1RAs) were associated with a lower risk of ...
Hosted on MSN1d
Semaglutide shortage ends as FDA sets deadline for compounders
With Novo Nordisk’s blockbuster drugs Wegovy and Ozempic back in stock, copycat versions of semaglutide are no longer allowed ...
Science Daily1d
Genetic evidence that diabetes drug GLP-1 receptor agonists achieve weight loss primarily by reducing fat mass more than muscle
Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have ...